Publications

2023

  • Toro C, Felmingham B, Jadhav M, Celermajer D, La Gerche A, O’Sullivan J, Kumar S, Mateos M, Fulbright J, Govender D, Collier L, Cheung M, Eisenstat D, Lange PW, Ayer J, Elliott D & Conyers R. Lessons learnt in the first year of an Australian Pediatric Cardio Oncology Clinic. BMC Cardio-Oncology (2023), Preprint: https://doi.org/10.21203/rs.3.rs-3281090/v1

 

  • Felmingham B, Toro C, Jadhav M, Elliott D & Conyers R. Designing and implementing a paediatric cardio-oncology clinic using Delphi consensus driven guidelines as a model to guide care. COSA ASM (2023), Oral presentation (Invited Speaker).

 

  • Finney J, Felmingham B, Kumar, S, Mahmood A, Wilson I, Horvath L, Celermajer D & Conyers R. Using the Australian Cardio-Oncology Registry to Study Long-Term Cancer Therapy Related Cardiac Dysfunction in Adults - The Chris O'Brien Lifehouse Experience. Medical Oncology Group of Australia MOGA (2023), Poster. 

 

  • Finney J, Felmingham B, Kumar, S, Mahmood A, Wilson I, Horvath L, Celermajer D & Conyers R. Using the Australian Cardio-Oncology Registry to Study Long-Term Cancer Therapy Related Cardiac Dysfunction in Adults - The Chris O'Brien Lifehouse Experience. San Antonio Breast Cancer Symposium SABCS (2023), Poster. 

 

  • Felmingham B, Toro C, Jadhav M, Elliott D & Conyers R. Pharmacist-Led Cardio-Oncology Clinic. Children’s Oncology Group, Atlanta USA (2023), Oral presentation (Invited Speaker).

 

  • Felmingham B, Toro C, Collier L, Jadhav M, Elliott D & Conyers R. An Approach to Implementing a Pharmacist Led Paediatric Led Paediatric Cardio-Oncology clinic in Australia. VCCC Alliance Conference (2023), Poster.

 

  • Felmingham B, Toro C, Collier L, Jadhav M, Elliott D & Conyers R. A Paediatric Cardio-Oncology Clinic: Review of data collected using newly established paediatric guidelines for patients receiving cancer therapy. VCCC Alliance Conference (2023), Poster.

 

  • Collier L, Felmingham B, Toro C, Celermajer D, Mateos M, Finney J, Naughtin C, Jadhav M, La Gerche A, Horvath L, O’Sullivan J, Ayer J, Fulbright J, Elliott D & Conyers R. The Australian Cardio-Oncology Registry: The importance of data management and data quality. ANZCHOG Perth (2023), Poster.

 

  • Felmingham B, Toro C, Collier L, Jadhav M, Elliott D & Conyers R. An Approach to Implementing a Pharmacist Led Paediatric Led Paediatric Cardio-Oncology clinic in Australia. ANZCHOG Perth (2023), Poster.

 

  • Felmingham B, Toro C, Collier L, Jadhav M, Elliott D & Conyers R. A Paediatric Cardio-Oncology Clinic: Review of data collected using newly established paediatric guidelines for patients receiving cancer therapy. ANZCHOG Perth (2023), Poster.

 

  • Collier L, Felmingham B, Toro C, Celermajer D, Mateos M, Finney J, Naughtin C, Jadhav M, La Gerche A, Horvath L, O’Sullivan J, Ayer J, Fulbright J, Elliott D & Conyers R. Australian Cardio-Oncology Registry: A prospective observational study of patients who have been exposed to cardio-toxic chemotherapy. Lorne Cancer Conference (2023), Poster.

 

2022

  • Toro C, Felmingham B, Jessop S, Celermajer D, Kotecha R, Govender D, Hanna D, O’Connor M, Manudhane R, Ayer J, O’Sullivan J, Sullivan M, Costello B, La Gerche A, Walwyn T, Horvath L, Mateos M, Fulbright J, Jadhav M, Cheung M, Eisenstat D, Elliott D & Conyers R. Cardio-Oncology Recommendation for Pediatric Oncology Patients: An Australian and New Zealand Delphi Consensus. JACC: Advances (2022), 1(5): 100155. https://doi.org/10.1016/j.jacadv.2022.100155

 

 

  • Felmingham B, Toro C, Jadhav M, Elliott D & Conyers R. Cardio-Oncology Guidelines for the paediatric patient. ANZCHOG Sydney (2022), Oral Presentation.

 

2021

  • Toro C, Elliott D, La Gerche A, Lange PW, Bolk F, O’Sullivan M, Bhatia K & Conyers R. Optimal detection of cardiac sequalae: The need for rigorous, harmonised magnetic resonance studies in paediatric survivors. JACC Cardio-Oncology (2021), 3(1): 154-156. https://doi.org/10.1016/j.jaccao.2021.01.010

 

  • Lapirow D, La Gerche A, Toro C, Masango E, Costello B, Porrello E, Ludlow L, Marshall G, Trahair T, Mateos M, Lewin J, Byrne J, Boutros R, Manudhane R, Heath J, Ayer J, Gabriel M, Walwyn T, Saundankar J, Forsey J, Le H, Mason K, Celermaje, D, Downie P, Walker R, Holland L, Martin M, McLeman L, Diamond Y, Marcocci M, Donath S, Cheung M, Elliott D & Conyers R. The Australian and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy related cardiotoxicity in a national cohort of paediatric cancer patients. Internal Medicine Journal (2021), 51(2): 229-234. https://doi.org/10.1111/imj.14719 

 

2020

  • Foulkes S, Costello B, Howden E, Janssens K, Dillon H, Toro C, Claus P, Fraser S, Daly R, Elliott D, Conyers R & La Gerche A. Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness. Journal of Cardiovascular Magnetic Resonance (2020), 22(1): 1-10. https://doi.org/10.1186/s12968-020-00658-4

 

  • McOwan T, Craig L, Tripdayonis A, Karavendzas K, Cheung M, Porrello E, Conyers R & Elliott D. Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy. JACC Cardio-Oncology (2020), 6: 1-16. https://doi.org/10.1186/s40959-020-00060-0

 

  • Foulkes S, Costello B, Howden E, Janssens K, Dillon H, Toro C, Fraser S, Daly R, Elliott D, Conyers R & La Gerche A. Exercise cardiac MRI unmasks cardiac dysfunction in childhood and adolescent cancer survivors with reduced cardiopulmonary fitness. European Heart Journal (2020), 41(2): 3275. https://doi.org/10.1093/ehjci/ehaa946.3275

 

2019

  • Tripaydonis A, Conyers R & Elliott D. Pediatric Anthracycline-Induced Cardiotoxicity: Mechanisms, Pharmacogenomics and Pluripotent Stem-cell Modelling. Clinical Pharmacology Therapeutics (2019), 105(3): 615-624. https://doi.org/10.1002/cpt.1311

 

  • Arasaratnam D, Bell KM, Sim CB, Koutsis K, Anderson DJ, Qian EL, Stanley EG, Elefanty AG, Cheung MM, Oshlack A, White AJ, Abi Khalil C, Hudson JE, Porrello ER & Elliott DA. The role of cardiac transcription factor NKX2-5 in regulating the human cardiac miRNAome. Scientific Reports (2019), 9(1): 15928. https://doi.org/10.1038/s41598-019-52280-9

 

  • Toro C & ACOR Steering Committee. Determining the best indicator of cardiac reserve for paediatric and young adult cancer patients: the Extended Cardiac Evaluation Study (ECES). ANCHOG ASM (2019), Poster.

 

  • Conyers R, Masango E, Byrne J, Trahair T, Forsy J, Gabriel M, Toro C, Mandhane R, Saundankar J, Walwyn T, La Gerche A, Heath J, Ludlow L, Celermajer D, Marcocci M, Lockwood L, Boutros R, Donath S, Le H & Elliott D. The establishment of the Australian Cardio-Oncology Registry (ACOR): Improving cardiovascular health outcomes of paediatric, adolescent and young adults cancer patients and survivors. ANCHOG ASM (2019), Oral presentation.

 

  • Foulkes S & ACOR Steering Committee. Exercise cardiac MRI unmasks cardiac dysfunction in childhood and adolescent cancer survivors with reduced cardiopulmonary fitness. Cardiac Society of Australia and New Zealand ASM (2019), Abstract.

 

2018

  • Conyers R, Devaraja S & Elliott D. Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patient. Paediatric Blood Cancer (2018), 65(4). https://doi.org/10.1002/pbc.26937

 

2017

  • Devaraja S & Conyers R. Systematic review of genetic polymorphisms associated with chemotherapy toxicity in paediatric cancer patients. ANZCNS 6th ASM (2017), Poster.

 

  • Conyers R, Costello B, La Gerche A, Tripaydonis A, Burns C, Ludlow L, Lange P, Elkert P, Mechinaud F, Cheung M, Martin M & Elliott D. Chemotherapy-related cardiotoxicity: are Australian practitioners missing the point? Internal Medicine Journal (2017), 47: 1166-1172. https://doi.org/10.1111/imj.13481

 

  • Craig LA, Ekert PG, Conyers & Elliott DA. Genetic determinants of anthracycline cardiotoxicity- ready for the clinic? British Journal of Clinical Pharmacology (2017), 83(5): 1141 – 1142. https://doi.org/10.1111/bcp.13195

 

2016

  • Tripaydonis A, Craig L, Ludlow LE, Cheung M, Mechinaud F, Ritchie D, Elliott D & Conyers R. Building a Targeted Approach to Assess Risk of Anthracycline Induced Cardiomyopathy Amongst Paediatric Cancer Patients. Blood (2016), 128(22): 5280. https://doi.org/10.1182/blood.V128.22.5280.5280